by Virovek Inc | Mar 11, 2021 | News
Hayward, California – March 10, 2021 Virovek is pleased to launch a new service line, producing adeno-associated virus (AAV) vector in human embryonic kidney HEK293 cells through three plasmid transfection method. See our HEK293 page for more details and...
by June Song | Aug 1, 2020 | News
Boston, Massachusetts, June 10-11, 2013 — Virovek was invited to present and showcase its large-scale AAV vector manufacturing process at this inaugural bio-manufacturing and processing summit (ManuBio USA 2013) to an audience composed of senior level delegates...
by June Song | Aug 1, 2020 | News
Hayward, California, June 3, 2013 — Virovek announced today it has discontinued its baculovirus titration kit, BacEZ Titer Kit, but will still provide technical support to customers who have previously purchased this product.
by June Song | Aug 1, 2020 | News
Nanjing, China, April 25-27, 2013 — Company CEO, Dr. Haifeng Chen, chaired the Gene Therapy session and presented Virovek’s latest suicide gene therapy technology using toxins to target cancer cells at the BIT’s 4th Annual World DNA and Genome Day...
by June Song | Aug 1, 2020 | News
San Francisco, California, January 7-9, 2013 — Virovek presented its newest patented technology to manufacture AAV vectors harboring toxins, the first of its kind, at the Biotech Showcase 2013 where private and small- and mid-cap biotechnology companies present...
by June Song | Aug 1, 2020 | News
San Francisco, California, and Houston, TX, May 16, 2012 — Avalanche Biotechnologies, Inc. and Lonza announced their major global manufacturing collaboration to use Virovek’s patented technologyto produce AAV vectors for gene therapy...